Key Segmentation
By Product
-
Infectious Disease Testing
-
Glucose Monitoring
-
Cardiometabolic Testing
-
Tumor/Cancer Marker Testing
-
Coagulation Testing
-
Pregnancy & Fertility Testing
-
Others
By Technology/Platform
-
Lateral Flow Assays
-
Molecular Diagnostics
-
Immunoassays
-
Microfluidics
-
Dipsticks
By Sample Type
-
Blood
-
Urine
-
Saliva/Oral Fluid
-
Others
By End User
-
Hospitals
-
Clinics/Physician Office Labs
-
Homecare/Self-Testing
-
Others
By Mode of Purchase
-
Prescription-Based
-
Over-the-Counter
Regional Coverage:
North America
-
United States
-
Canada
Europe
-
Germany
-
United Kingdom
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Key players in the Point of Care Diagnostics/Testing Market include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Danaher Corporation, Siemens Healthineers AG, and Becton, Dickinson and Company (BD), among others.
-
Key opportunities in the Point of Care Diagnostics/Testing Market include integration with wearables and mobile health platforms for continuous patient monitoring and AI-assisted result interpretation extending rapid testing into less specialized care settings.
The market is driven by rising global prevalence of chronic conditions requiring frequent monitoring, combined with continued infectious disease burden and the ongoing shift toward decentralized, near-patient healthcare delivery.
The Infectious Disease Testing segment dominated the Point of Care Diagnostics/Testing Market, accounting for approximately 30.50% market share.
North America dominated the Point of Care Diagnostics/Testing Market in 2025 with approximately 37.10% share, driven by a large hospital network and strong retail pharmacy testing adoption.